id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-N-0474-0003,FDA,FDA-2008-N-0474,"Time and Extent Application (TEA) from  L'Oreal USA Products, Inc., and Reference 1 - TEA for Ecamsule (Terephthalylidene Dicamphor Sufonic Acid) dated September 18, 2007, Background Material Book 2",Supporting & Related Material,Background Material,2008-09-15T04:00:00Z,2008,9,,,2015-02-18T19:45:14Z,,0,0,090000648070674b
FDA-2008-N-0474-0002,FDA,FDA-2008-N-0474,"Time and Extent Application (TEA) from L'Oreal USA Products, Inc., and Reference 1 - TEA for Ecamsule (Terephthalylidene Dicamphor Sufonic Acid) dated September 18, 2007, Background Material Book 1",Supporting & Related Material,Background Material,2008-09-15T04:00:00Z,2008,9,,,2015-02-18T19:42:31Z,,0,0,0900006480706718
FDA-2008-N-0474-0005,FDA,FDA-2008-N-0474,"Report/Review of Time and Extent Application (TEA) from FDA CDER for L'Oreal USA Products, Inc., TEA (Terephthalylidene Dicamphor Sufonic Acid) dated September 25, 2007",Supporting & Related Material,Report,2008-09-15T04:00:00Z,2008,9,,,2015-02-18T19:48:57Z,,0,0,09000064807067a2
FDA-2008-N-0474-0004,FDA,FDA-2008-N-0474,"Time and Extent Application (TEA) Amendment from  L'Oreal USA Products, Inc., and Reference 1 - TEA for Ecamsule (Terephthalylidene Dicamphor Sufonic Acid) dated February 5, 2008",Supporting & Related Material,Background Material,2008-09-15T04:00:00Z,2008,9,,,2015-02-18T19:46:06Z,,0,0,0900006480706777
FDA-2008-N-0474-0001,FDA,FDA-2008-N-0474,Ecamsule Eligibility for Inclusion in Monograph; Over-the-Counter Sunscreen Drug Products for Human Use; Request for Safety and Effectiveness Data,Notice,Requests for Information (RFI),2008-09-12T04:00:00Z,2008,9,2008-09-12T04:00:00Z,2008-12-12T04:59:59Z,2015-02-20T03:01:32Z,E8-21291,0,0,09000064807017ef